News|Podcasts|August 2, 2023
The Business Case for Patient Centricity
Author(s)ZS Associates
Sharon Suchotliff, associate principal at ZS and lead for patient centricity, discusses why patient centricity has become a business imperative for life sciences companies. Sharon delves into the measurement of patient centricity, provides examples of how different companies have approached this and ZS’s approach for Patient Outcomes Impact (POI).
Related Content
Trending on PharmExec
1
FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report
2
Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?
3
How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs
4
Private Equity in Healthcare After Connecticut: Why the Life Sciences Industry Needs Stewardship Capital, Not Financial Engineering
5